Impedimed Net Income from 2010 to 2026
| IPD Stock | 0.02 0 5.56% |
Net Loss | First Reported 2007-12-31 | Previous Quarter -6.2 M | Current Value -12.1 M | Quarterly Volatility 3.6 M |
Check Impedimed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Impedimed's main balance sheet or income statement drivers, such as Interest Expense of 1.3 M, Selling General Administrative of 14.1 M or Total Revenue of 15.4 M, as well as many indicators such as . Impedimed financial statements analysis is a perfect complement when working with Impedimed Valuation or Volatility modules.
Impedimed | Net Income |
The evolution of Net Income for Impedimed provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Impedimed compares to historical norms and industry peers.
Latest Impedimed's Net Income Growth Pattern
Below is the plot of the Net Income of Impedimed over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Impedimed financial statement analysis. It represents the amount of money remaining after all of Impedimed operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Impedimed's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Impedimed's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (23.24 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Impedimed Net Income Regression Statistics
| Arithmetic Mean | (19,203,788) | |
| Coefficient Of Variation | (32.88) | |
| Mean Deviation | 5,026,684 | |
| Median | (20,706,000) | |
| Standard Deviation | 6,314,755 | |
| Sample Variance | 39.9T | |
| Range | 19.6M | |
| R-Value | (0.57) | |
| Mean Square Error | 28.7T | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | (712,078) | |
| Total Sum of Squares | 638T |
Impedimed Net Income History
About Impedimed Financial Statements
Impedimed shareholders use historical fundamental indicators, such as Net Income, to determine how well the company is positioned to perform in the future. Although Impedimed investors may analyze each financial statement separately, they are all interrelated. The changes in Impedimed's assets and liabilities, for example, are also reflected in the revenues and expenses on on Impedimed's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Impedimed Stock Analysis
When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.